Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the treatment of diabetic macular edema ...

Broader markets outperformed the benchmarks, with small-cap shares leading the charge, as the Nifty Smallcap100 index ended ...

Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company dedicated to the prevention and treatment of ...

Opthea's lead compound, sozinibercept, targets VEGF-C/D and is in Phase 3 trials for wet AMD. Read more to see why I'm ...

The MIT researchers were able to significantly increase the flight time of an insect-sized flapping wing robot compared to ...

Richard Gill lives in an 18th century farmhouse in Caunton, near Newark, Notts, which he has fitted with a ground-mounted ...

At 12 weeks of follow-up, adults with elevated CRP (defined as >0.30 mg/dL) at baseline -- whose ... the authors concluded in their research letter in JAMA Dermatology. The drug still worked ...

Hyundai Motor Company has unveiled E3W and E4W electric last-mile mobility concepts in India at Auto Expo 2025 and is ...

Detailed price information for Ocular Therapeut (OCUL-Q) from The Globe and Mail including charting and trades.

Ravindra Energy has received a Letter of Award from ‘Maharashtra State ... for Eculizumab concentrate for solution for infusion 300 mg (10mg/ml) (SOLIRIS). Eculizumab is indicated for the ...

In our annual review of developments in Canadian patent law, we considered over 60 court decisions reported last year. In ...